Hasta la próxima

Auto reproducción

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma

3 vistas • 07/18/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción